Aripiprazole induced acute transient bilateral myopia: A case report

Background: Aripiprazole is an atypical antipsychoticdrug. Acute transient myopia is a rare response to sys-temic medication. Unspecified ocular side effects ofaripiprazole have rarely been reported. To the best ofour knowledge, only 3 cases of aripiprazole inducedmyopia and diplopia have been reported in the litera-ture. The aim of this article is to present a case of ar-ipiprazole-induced acute transient myopia.Case Report: A 30 year-old woman underwent treat-ment for 5 days with aripiprazole and presented withbilateral painless blurred vision. The patient s uncor-rected visual acuity was 2/10 in both eyes and her bestcorrected visual acuity was 10/10 in both eyes witha refractive error of -3.00 diopters using a standard Snellen chart. Adding 2 mgs of biperiden a day to hertreatment regimen decreased her blurred vision symp-toms. After discontinuation of aripiprazole treatmentand cross-switching to Paliperidon palmitate (75 mg/month) her blurred vision completely resolved. Thesame side effect did not re-occur when checked on her6-month follow up.Conclusion: Ophthalmologists as well as psychiatristsmust be aware of this myopic shift and should also askthese patients about medicine usage, especially aripip-razole. Ophthalmologists should consult the prescrib-ing psychiatrist and stop the drug immediately to re-verse this temporary condition.Keywords: Aripiprazole, drug induced, myopia, transient

PDF

___

1. Swainston Harrison T, Perry CM. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder. Drugs 2004;64:1715-36. [CrossRef]
2. Burris KD, Molski TF, Xu C, Ryan E, Tottori K, Kikuchi T, et al. Aripiprazole, a novel antipsychotic, is a high-affinity partial ag- onist at human dopamine D2 receptors. J Pharmacol Exp Ther 2002;302:381-9. [CrossRef]
3. Shapiro DA, Renock S, Arrington E, Chiodo LA, Liu LX, Sibley DR, et al. Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology. Neuropsychopharmacology 2003;28:1400-11. [CrossRef]
4. Szawarski P, Hall-Thompson B. Acetazolamide-induced myopia at altitude. Wilderness Environ Med 2009;20:300-1. [CrossRef]
5. Milea D, Zech C, Dumontet C, Coiffier B, Trepsat C. Transient acute myopia induced by antilymphocyte globulins. Ophthalmo - logica 1999;213:133-4. [CrossRef]
6. Kaya H, Yılbas B, Dilbaz N, Yazar Z. Aripiprazole induced acute myopia: a case report. Bull Clin Psychopharmacol 2009;19(Suppl 1):147-8.
7. Selvi Y, Atli A, Aydin A, Yener HI. Aripiprazole-related acute transient myopia and diplopia: a case report. J Clin Psychophar- macol 2011;31:249-50. [CrossRef]
8. Nair AG, Nair AG, George RJ, Biswas J, Ghandi RA. Aripipra- zole induced transient myopia: a case report and review of litera- ture. Cutan Ocul Toxicol 2012;31:74-6. [CrossRef]
9. Berman RM, Fava M, Thase ME, Trivedi MH, Swanink R, Mc- Quade RD, et al. Aripiprazole augmentation in major depres- sive disorder: a double-blind, placebo-controlled study in pa- tients with inadequate response to antidepressants. CNS Spectr 2009;14:197-206.
10. Berman RM, Marcus RN, Swanink R, McQuade RD, Carson WH, Corey-Lisle PK, et al. The efficacy and safety of aripipra- zole as adjunctive therapy in major depressive disorder: a mul- ticenter, randomized, double-blind, placebo-controlled study. J Clin Psychiatry 2007;68:843-53. [CrossRef]
11. Atlı A, Selvi Y, Yıldız A, Kaya MC. Aripiprozole-induced diplo - pia: a case report. BCP 2013;23:353-6. [CrossRef]